CIK 0001412558 · Pharmaceutical Preparations (SIC 2834) · Nasdaq, OTC · incorporated in 2M · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-15 | 6-K | FORM 6-K | 2026-10-15 |
| 2026-10-14 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-10-14 | 6-K | FORM 6-K | 2026-10-14 |
| 2026-09-29 | 6-K | FORM 6-K | 2026-09-29 |
| 2026-09-09 | 6-K | FORM 6-K | 2026-09-09 |
| 2026-08-13 | 6-K | FORM 6-K | 2026-08-13 |
| 2026-07-14 | 6-K | FORM 6-K | 2026-07-13 |
| 2026-06-30 | 6-K | FORM 6-K | 2026-06-30 |
| 2026-06-17 | 6-K | FORM 6-K | 2026-06-17 |
| 2026-05-06 | 6-K | FORM 6-K | 2026-05-06 |
| 2026-05-01 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-04-30 | 6-K | FORM 6-K | 2026-04-29 |
| 2026-04-24 | 6-K | FORM 6-K | 2026-04-24 |
| 2026-04-08 | 6-K | FORM 6-K | 2026-04-08 |
| 2026-04-08 | 20-F | FORM 20-F | 2025-12-31 |
| 2026-04-07 | 6-K | FORM 6-K | 2026-04-07 |
| 2026-04-06 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-03-30 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-03-10 | 6-K | FORM 6-K | 2026-03-10 |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-01-16 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-01-16 | 6-K | FORM 6-K | 2026-01-16 |
| 2026-01-13 | 6-K | FORM 6-K | 2026-01-13 |
| 2026-01-08 | 6-K | FORM 6-K | 2026-01-08 |
| 2026-01-06 | 6-K | FORM 6-K | 2026-01-06 |
Forms on file (last 1,000): 6-K 91, 425 14, UPLOAD 10, CORRESP 9, 20-F 8, CT ORDER 6, SCHEDULE 13D/A 4, F-1/A 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=EVO (0.002 USD), /gw/filings/filings?ticker=EVO&form=8-K, /gw/filings/facts?ticker=EVO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange